Counterpoint: Sorting wheat from chaff

Journal of Clinical Lipidology

Volumn 2, Issue 4, 2008, Pages 306-307

  Patel, Shailendra B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PHYTOSTEROL; SIMVASTATIN; SITOSTEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EDITORIAL; FOLLOW UP; FOOD COMPOSITION; GALLSTONE; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ABSORPTION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

TRITICUM AESTIVUM;

EID: 48749114574     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.06.006     Document Type: Editorial

References (16)

1. Miettinen T.A., Gylling H., Strandberg T., and Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 316 (1998) 1127-1130
2. Sies H. A new parameter for sex education. Nature 332 (1988) 495
3. Serizawa S., Otsuka H., Seyama Y., and Yamakawa T. Studies on the biosynthesis of cholestanol in cultured cells. J Biochem 92 (1982) 1547-1557
4. Norlin M., von Bahr S., Bjorkhem I., and Wikvall K. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. J Lipid Res 44 (2003) 1515-1522
5. Panzenboeck U., Andersson U., Hansson M., Sattler W., Meaney S., and Björkhem I. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. J Lipid Res 48 (2007) 1167-1174
6. Berge K.E., von Bergmann K., Lutjohann D., et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 43 (2002) 486-494
7. Boomsma D.I., de Geus E.J., Vink J.M., et al. Genetic analysis of indicators of cholesterol synthesis and absorption: lathosterol and phytosterols in Dutch twins and their parents. Twin Res 6 (2003) 307-314
8. Sehayek E., Duncan E.M., Lutjohann D., et al. Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J x CASA/Rk intercross. Proc Natl Acad Sci U S A 99 (2002) 16215-16219
9. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., and Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis 16 (2006) 13-21
10. Wilund K.R., Yu L., and Xu F. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 24 (2004) 2326-2332
11. Pinedo S., Vissers M.N., von Bergmann K., et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 48 (2007) 139-144
12. Fassbender K., Lütjohann D., Dik M.G., et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis 196 (2008) 283-288
13. Grünhage F., Acalovschi M., Tirziu S., et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 46 (2007) 793-801
14. Canner P.L., Berge K.G., Wenger N.K., et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 8 (1986) 1245-1255
15. Salen G., von Bergmann K., Lütjohann D., et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109 (2004) 966-971
16. Assmann G., Kannenberg F., Ramey D.R., Musliner T.A., Gutkin S.W., and Veltri E.P. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 24 (2008) 249-259